For immortal growth, glioma cells exhibit telomere maintenance mechanisms (TMMs), which are TERTp mutation in O_IDH_mut and IDH-wildtype GBM and ATRX mutation in the majority of astrocytomas and histone-mutant pediatric-type high-grade gliomas29. This evidence concerns the gene IDH2 and central nervous system cancer.